Clateo Castellini

MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore.

Part of AsiaMedic Ltd., AsiaMedic Eye Centre Pte Ltd. operates as an investment holding Singaporean company with an interest in providing healthcare services.

AsiaMedic Astique The Aesthetic Clinic Pte Ltd. provides health care services. The company is headquartered in Singapore.

Part of Luye Pharma Group Ltd., Luye Biotech (Singapore) Pte Ltd. is a Singaporean company that provides pharmaceutical research services. The company is based in Singapore, Singapore.

Part of Luye Pharma Group Ltd., Asiapharm Investments Ltd. is an investment holding Chinese company. The company is based in Hong Kong, Hong Kong.

Luye Medical Group Pte. Ltd. provides healthcare services. It offers technology, operational, and management systems for healthcare services to global and local customers. The company was founded in 2015 and is headquartered in Singapore.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award.

EDBI Pte Ltd. provides investment services. It offers investments in biomedical sciences, information and communication technology, smart and sustainable technology. The company was founded in 1991 and is headquartered in Singapore.

Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore.

ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore.

EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore.

Singapore Suzhou Township Development Pte Ltd. provides real estates services. It also engages in harbor and related offshore structure construction. The company is headquartered in Singapore.

National Healthcare Group Pte Ltd. provides public healthcare services. It offers care through an integrated network and collaborate with hospitals, specialty centres, polyclinics, patients, caregivers, partners, volunteers and the community. The company is headquartered in Singapore.

Biomedical Sciences Investment Fund Pte Ltd seeks investment opportunities in Singapore, Europe, Asia and the US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals and medical technology companies. It provides financing for early stage capital requirements.

Alexandra Health System Pte Ltd. provides multi-disciplinary and holistic care services for patients.

Anext Bank Pte Ltd is a digital wholesale bank based in Singapore, SG. Anext Bank is dedicated to accelerating fintech development and financial inclusion in Singapore and the region through continuous technology-driven innovation. The Singaporean company focuses on providing innovative and secure digital financial services to local and regional micro, small and medium enterprises (SMEs) to aid their growth and expansion.

Part of AsiaMedic Ltd., Complete Healthcare International Pte Ltd. provides healthcare services. The company is based in Singapore, Singapore. The CEO of the Singaporean company is Kae Thong Wong. Complete Healthcare International was acquired by AsiaMedic Ltd. on February 23, 2017 for $1.62 million.